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Objective: To establish sex-speciﬁc (subregional) reference values of cartilage thickness and potential
maximal Z-scores in the femorotibial joint.
Methods: The mean cartilage thickness (ThCtAB.Me) in femorotibial compartments, plates and subre-
gions was determined on coronal magnetic resonance imaging (MRI) from a population-based sample
(Framingham) and from a healthy reference sample of the Osteoarthritis Initiative (OAI).
Results: 686 Framingham participants (309 men, 377 women, age 62 8 years) had no radiographic
femorotibial osteoarthritis (OA) (“normals”) and 376 (156 men, 220 women) additionally had no MRI
features of cartilage lesions (“supernormals”). The Framingham “normals” had thinner cartilage in the
medial (3.59 mm) than in the lateral femorotibial compartment (3.86 mm). Medially, the femur displayed
thicker cartilage (1.86 mm) than the tibia (1.73 mm), and laterally the tibia thicker cartilage (2.09 mm)
than the femur (1.77 mm). The thickest cartilage was observed in central, and the thinnest in external
femorotibial subregions. Potential maximal Z-scores ranged from 5.6 to 9.8 throughout the subregions;
men displayed thicker cartilage but similar potential maximal Z-scores as women. Mean values and
potential maximal Z-scores in Framingham “supernormals” and non-exposed OAI reference participants
(112 participants without symptoms or risk factors of knee OA) were similar to Framingham “normals”.
Conclusions:We provide reference values and potential maximal Z-scores of cartilage thickness in middle
aged to elderly non-diseased populations without radiographic OA. Results were similar for “super-
normal” participants without MRI features of cartilage lesions, and in a cohort without OA symptoms or
risk factors. A cartilage thickness loss of around 27% is required for attaining a Z-score of 2.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Cartilage morphology as determined quantitatively with
magnetic resonance imaging (MRI) is being widely explored as
a biomarker of disease status and progression in knee osteoarthritis
(OA)1e5. Although an issue yet to be proven, it is also assumed that
subjects with knee OA, whose cartilage thickness deviates from the
normal range, may have a poorer prognosis than those whose
cartilage thickness is in the normal range, and that the prognosis: Felix Eckstein, Institute of
ergasse 21, A5020 Salzburg
002-1249.
in).
s Research Society International. Pworsens as subjects progressively deviate from the normal range,
eventually resulting in bone-to-bone contact. The cross-sectional
evaluation of how much cartilage tissue has been lost at different
stages of disease, however, requires reliable reference values from
healthy subjects without knee OA, preferably from large pop-
ulation-based studies. Some investigators have provided mean
values and standard deviations (SDs) from relatively small groups
of normal healthy volunteers6e10, but it remains unclear how
representative these volunteers are with respect to the general
population as to date, no values have been provided from large
population-based studies. Recent longitudinal studies indicated
that cartilage loss does not occur homogeneously throughout the
femorotibial joint, but is greater in certain femorotibial sub-
regions11e14. Therefore, it may be preferable to determine cartilageublished by Elsevier Ltd. All rights reserved.
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requiring “reference values” also for speciﬁc femorotibial
subregions14,15.
The potential of estimating cartilage loss in cross-sectional
studies is deﬁned by (1) the difference between the mean values
(for given femorotibial subregions) in a healthy reference pop-
ulation and “zero” (100% cartilage loss) and (2) the normal inter- or
between-subject variability of the reference population. Z-scores or
“standard” scores8 indicate how many SDs an observation is above
or below the mean of healthy subjects of the same age and sex. In
the current context, therefore, Z-scores represent the difference
between the measured cartilage thickness (in a patient) and the
healthy cartilage thickness from a reference sample, divided by
the betweenesubject SD in the healthy reference sample. The
greater the cartilage thickness and the smaller the between-
subject SD, the greater the maximal potential Z-score8, and the
greater the potential to detect whether a sample or a person
studied cross-sectionally has indeed experienced cartilage loss.
Although a cartilage thickness value of “zero” is a very unlikely
event, even in end-stage knee OA, it is useful to explore which
maximal Z-scores can be expected in different femorotibial
compartments, plates, and subregions.
The primary objective of this paper was thus to establish sex-
speciﬁc (subregional) reference values of normal femorotibial
cartilage thickness (ThCtAB) from a large population-based
cohort, and to determine the maximal potential (subregional)
Z-scores for cross-sectional comparisons. Secondary objectives
were to investigate to what extent selection of a “supernormal”
group (no radiographic femorotibial OA and no MRI features of
femorotibial cartilage lesions) produces reference values different
from one that is considered “normal” based on radiographic
evaluation alone. A related secondary objective was to explore
whether the healthy sample from theOA Initiative cohort,which has
not been exposed to risk factors for knee OA, displays values similar
to those of the population-based study (Framingham) and can be
used as an internal control for OAI participants with knee OA.
Methods
Framingham study sample
Participants were members of the Framingham OA Study
Cohort16e18. This cohort consists of two subgroups: (1) members of
the Framingham Heart Study Offspring study19, a longitudinal
population-based cohort study to examine risk factors for heart
disease20, and (2) a newly recruited community sample cohort
from the town of Framingham, MA. Both subgroups were used in
the current study. The ﬁrst subgroup (Framingham Heart Study
Offspring Cohort) has been described previously21, and all active
members of this group, whose parents had been studied for OA22,
received a letter of invitation and follow-up phone call for
recruitment purposes. A validated survey instrument supple-
mented by questions about medication use was used to exclude
persons with rheumatoid arthritis23. The second subgroup con-
sisted of participants of the newly recruited community sample
who were drawn from a random sample of the Framingham
community. Subjects had to be aged 50e80 years, and ambulatory
(use of assistive devices such as canes and walkers was allowed).
Exclusion criteria were bilateral total knee replacements or rheu-
matoid arthritis as deﬁned above and contraindications to MRI23. In
neither of the two above groups were participants selected based
on the presence or absence of knee OA, or risk factors of knee OA.
Approval for the study in this combined group, designated the
Framingham OA Study cohort, was obtained from the Boston
University Medical Center Institutional Review Board and theparticipants were examined in 2002e200516e18. The study protocol
involved acquisition of posterioreanterior (PA) ﬁxed ﬂexion
radiographs of both knees24. For the purpose of the current anal-
ysis, only participants with a femorotibial Kellgren Lawrence (KL)
grade of 025 on PA views were included in the “normal” reference
cohort.
MRI examinations of both knees were performed using a 1.5
Tesla (T) magnet (Siemens Symphony, Erlangen, Germany), unless
one had a total knee prosthesis, in which case only one knee was
imaged. In the Framingham Offspring subgroup, only participants
reporting knee pain, aching or stiffness underwent MRI of the right
knee, whereas MRIs were acquired in all members of the
Community Cohort, regardless of symptom status.
For the purpose of semi-quantitative assessment of cartilage
morphology, sagittal, coronal and axial proton density (PD)-
weighted fat-suppressed images were acquired18. For the
purpose of quantitatively measuring (subregional) cartilage
morphology, coronal fast low angle shot sequences with water
excitation (FLASHwe) were acquired with a 1.5 mm slice thick-
ness and a 0.31 mm 0.31 mm in-plane resolution in all right
knees17,18.Osteoarthritis initiative (OAI) study sample
The OAI is a large ongoing cohort study, targeted at charac-
terizing risk factors associated with the onset and progression of
symptomatic knee OA, and at identifying biomarkers of the
disease. Of the 4796 OAI participants, 122 represent a non-
exposed healthy reference subcohort (public-use data set 0.F.1).
The inclusion criteria for this subcohort are described on the OAI
webpage (http://www.oai.ucsf.edu/datarelease/) and in Appendix
1; the participants had no symptoms or radiographic ﬁndings of
knee OA, and no risk factors for knee OA (i.e., non-exposed
cohort); they were 45e79 years old and included a diversity of
ethnic minorities. General exclusion criteria (for all OAI partici-
pants) were rheumatoid or inﬂammatory arthritis, bilateral, end-
stage knee OA, inability to walk without aids, and MRI
contraindications.
The OAI imaging protocol included a coronal FLASHwe protocol
with a spatial resolution identical to that used in the Framingham
study, but acquired at 3T (Siemens Trio, Erlangen,
Germany)12,26e28. From the 122 participants of the non-exposed
reference subcohort, 112 had usable coronal FLASHwe acquisitions
of the right knee.Semi-quantitative cartilage scoring (Framingham sample)
In the Framingham (but not in the OAI) study sample, the
whole-organ MRI scoring method (WORMS) described by Peterfy
et al.29 was used for semi-quantitative grading of articular cartilage
integrity: 0¼ normal thickness and signal; 1¼ normal thickness
but increased signal on PD-/T2-weighted images; 2¼ partial-
thickness focal defect <1 cm at its greatest width; 2.5¼ full-thick-
ness focal defect <1 cm at its greatest width; 3¼multiple areas of
partial-thickness (grade 2) defects intermixed with areas of normal
thickness, or a grade 2 defect wider than 1 cm but <75% of the
region; 4¼ diffuse (75% of the region) partial-thickness loss;
5¼multiple areas of full-thickness loss (grade 2.5) or a grade 2.5
lesionwider than 1 cm but<75% of the region; 6¼ diffuse (75% of
the region) full-thickness loss. Cartilage was evaluated in 10 fem-
orotibial regions: anterior, central, and posterior segments of the
medial and lateral femur and tibia. Because the focus was on
femorotibial cartilage, patello-femoral regions were not included.
Table I
Subject characteristics of the population-based Framingham cohort and of the OAI
non-exposed reference cohort
Framingham
normal
Framingham
supernormal
OAI
Men n¼ 309 n¼ 156 n¼ 43
Mean SD Mean SD Mean SD
Age 62.9 8.8 60.3* 7.4 57.0y 9.6
Height 174.6 7.5 174.3 7.6 174.9 6.9
Weight 86.3 14.7 86.0 14.8 79.3y 8.2
BMI 28.3 4.3 28.3 4.5 26.1y 3.0
Women n¼ 377 n¼ 220 n¼ 69
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Segmentation of the femorotibial cartilage was performed using
the coronal three-dimensional (3D) FLASHwe by readers from the
same group in both the Framingham and in the OAI healthy refer-
ence sample12,17,18,28. These had received a formal training in
cartilage segmentation using custom software (Chondrometrics
GmbH). Manual tracing of the total subchondral bone area (tAB)
and the cartilage joint surface area (AC) of the medial tibia (MT),
lateral tibia (LT), central (weight-bearing) medial femoral condyle
(cMF) and central (weight-bearing) lateral femoral condyle
(cLF)4,30,31 was performed, as well as quality control readings of all
segmentations. Whereas the intercondylar bone bridge was used
for deﬁning the posterior end of the femoral (weight-bearing)
region of interest in the Framingham study32, a 60% criterion
(distance from trochlear notch to posterior ends of the femoral
condyles) was used in the OAI30. The segmentations were then used
to compute the cartilage thickness over the entire subchondral
bone area, including denuded areas as 0 mm cartilage thickness
(ThCtAB)4. Results for the medial and lateral femorotibial
compartments (MFTC/LFTC) were obtained by summing values of
MT and cMF, and LT and cLF, respectively31,33. Then, ﬁve tibial
subregions (central¼ cMT/cLT, internal¼ iMT/iLT, external¼ eMT/
eLT, anterior¼ aMT/aLT, posterior¼ pMT/LT) were determined,
with the central subregion occupying 20% of the tAB15. The weight-
bearing femoral condyles were divided into three subregions
(central¼ ccMF/ccLF, internal¼ icMF/icLF, and external¼ ecMF/
ecLF), each occupying 33.3% of the tAB.
Statistical analysis
Descriptive statistics for femorotibial compartments, plates and
subregions were given as mean SD ThCtAB in men and women
separately, since previous studies have shown signiﬁcant differences
betweensexes9,34. PotentialmaximalZ-scores (standard scores)were
derived by dividing the difference between the mean value and zero
by the inter-subject SD in each compartment, plate and subregion.
Please note that the current paper does not report “observed” Z-
scores for patients with knee OA, but computes theoretical (or
“potential”) maximal Z-scores, based on the normal distribution of
cartilage thickness in various knee compartments, plates and subre-
gions, under the assumption that the minimal cartilage thickness in
these may attain values of “zero” in end-stage knee OA.
To test the hypothesis that the reference values for cartilage
thickness from supernormal Framingham participants (without
cartilage lesions apparent from semi-quantitative MRI scores) were
different from normal (but not supernormal) Framingham partici-
pants (i.e., subjects with normal radiographs, but with cartilage
lesions apparent fromMRI), a regression model with mean outcome
as a function of group assignment and covariates was applied. The
comparison was adjusted for differences in age, height, and weight;
differences between groups were considered to be signiﬁcant if
P< 0.01 (in view of the relatively large sample and in order to mini-
mize the number of false positive comparisons), but no adjustment
for multiple comparisons was made. The hypothesis that the mean
values for cartilage thickness in the OAI non-exposed reference
cohortwere different fromthat in thepopulation-based Framingham
normal cohort was tested in the same way as described above.Age 61.7 7.9 61.2 7.8 53.8y 6.0
Height 160.8 6.7 160.7 6.7 163.5y 6.5
Weight 71.6 15.6 71.0 15.8 61.9y 8.2
BMI 27.7 5.8 27.5 5.9 23.1y 2.5
* Signiﬁcantly different compared with those of the Framingham normal cohort
that were not supernormal (n¼ 153) at P< 0.01.
y Signiﬁcantly different compared with those of the Framingham normal cohort
(n¼ 309) at P< 0.01.Results
Demographics
From 2306 subjects investigated in the Framingham cohort,
1080 received MRI acquisitions of at least one knee. Of those, 686(309men, 377women) had no sign of radiographic femorotibial OA
in PA radiographic views and were considered a “normal” reference
group. Subject characteristics are given in Table I.
310 (153 men, 157 women) of the 686 Framingham “normals”
displayed MRI-based features of cartilage lesions (i.e., a WORMS
cartilage score >0 [n¼ 289], a denuded subchondal bone area in
the quantitative analysis [n¼ 30], or both [n¼ 9] in any weight-
bearing femorotibial cartilage plate). The 376 participants without
these features (156 men; 220 women) were considered a “super-
normal” reference group. There was no signiﬁcant difference in
the subject characteristics of “supernormal” (n¼ 220) and non-
supernormal women (n¼ 157). The supernormal men (n¼ 156)
were signiﬁcantly younger (Table I) than the non-supernormal
men (n¼ 153). Of the 112 subjects in the non-exposed OAI sub-
cohort, 43 were men and 69 women. Both the men and women
were signiﬁcantly younger and had a signiﬁcantly lower body
weight and BMI than the same sex Framingham normals; the
women also were signiﬁcantly taller than the Framingham
participants (Table I).
Cartilage thickness reference values and Z-scores in Framingham
normals
Averaging values of men and women in 686 Framingham
normals, the cartilage in the MFTC (3.59 mm) was somewhat
thinner than that in the lateral compartment (3.86 mm; Fig. 1),
whilst the SD of the thickness was similar for both compartments.
Medially, the femur (cMF) displayed a somewhat greater cartilage
thickness (1.86 mm) than the tibia (MT, 1.73 mm), but laterally the
tibia (LT) had thicker cartilage (2.09 mm) than the femur (cLF,
1.77 mm). In all femorotibial plates the central subregions dis-
played thicker cartilage than the peripheral subregions; the carti-
lage was thinnest in the external subregions (Fig. 1). cLT displayed
the thickest cartilage (3.13 mm), and ecMF the thinnest cartilage
(1.37 mm) across all subregions (Fig. 1).
The men displayed thicker cartilage thickness than women
(Table II, Fig. 2) throughout all plates and subregions. Histograms
of the cartilage thickness distribution in the MT of men and
women, respectively, are displayed in Fig. 3. In men, the maximal
Z-scores for compartments, plates and subregions ranged from
6.1 (ecMF) to 9.8 (LFTC), and in women from 5.6 (ccMF) to 9.3
(LFTC). When averaged across compartments, plates and subre-
gions, the maximal Z-scores were similar in men (7.5) and
women (7.3).
Fig. 1. Schematic showing (A) View of the central (weight-bearing) femoral condyles (cMF/cLF) from inferior, (B) View of the central (weight-bearing) femoral condyles (cMF/cLF)
and tibiae (MT/LT) from posterior, (C) View of the tibiae (MT/LT) from superior. Mean values and SDs of cartilage thickness (ThCtAB, averaged for men and women) from 686 normal
subjects (KL grade 0) of the Framingham cohort are shown for femorotibial compartments, plates and subregions: MFTC¼MTþcMF, LFTC¼ LTþcLF; subregion labels: c¼ central,
e¼ external, i¼ internal, a¼ anterior, p¼ posterior.
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supernormals
Mean thickness values in the Framingham supernormals (Table
III) were within 0.06 mm (2.6%) of those in Framingham normals
across all compartments, plates and subregions (Table II, Fig. 2). The
differences ranged from 0.06 mm and 2.6% (both ccLF) to
þ0.05 mm (cLT) and þ1.9% (pLT) in men, and from 0.05 mm and
2.5% (both ccLF) to þ0.03 mm (cLT) and þ1.0% (pLT) in women
(Table III). Across the 22 subregions, 14 had smaller values in Fra-
mingham “supernormals” compared with normals, and eight
showed larger or the same values (men and women). When
comparing the results in the supernormals with non-supernormals,
the only plate with signiﬁcant differences was cLF in women
(Table III, Fig. 2). No subregion in the supernormal men showed
signiﬁcantly different values from non-supernormal normals after
adjustment for age, weight, and height, but two subregions in
supernormal women did (ccLF, icLF; Table III). The maximal Z-
scores were similar in supernormals (7.6 in men, 7.8 inwomen) and
non-supernormal Framingham normals (7.5 and 7.3), when being
averaged across compartments, plates and subregions.Cartilage thickness reference values and Z-scores in non-exposed
OAI participants
The mean cartilage thickness (ThCtAB.Me) values in the non-
exposed OAI subcohort (Table IV) were also similar to the Fra-
mingham normals (Table II), with differences of less than 0.2 mm
and 8.2% in all compartments, plates and subregions. The differ-
ences ranged from 0.09 mm (MFTC) and 5.3% (ecLF) to
þ0.19 mm (cLT) and þ7.6% (eLT) in men, and from 0.15 mm and
7.6% (both pLT) to þ0.12 mm and þ8.2% (both eLT) in women.
Across the 22 cartilage regions, 14 displayed smaller and eight
greater values in male OAI participants compared with Framing-
ham normals. Nine of the 22 regions displayed smaller values, nine
greater values, and four the same values in female OAI participants
compared with Framingham normals (Table III). There were no
signiﬁcant differences in cartilage plates or compartments between
the non-exposed OAI and the Framingham participants, but one
subregion (eLT; Table IV) in OAI men and three subregions in OAI
women (eLT, aLT, pLT; Table IV) showed values signiﬁcantly
different from Framingham normals. In men, the maximal Z-scores
for compartments and plates ranged from 7.1 (cMF) to 9.7 (LFTC),
Table II
Framingham normal cohort (n¼ 686); participants without radiographic femoroti-
bial OA (KL grade 0): Mean values (mean), 95% conﬁdence interval (CI) of the mean
SD and Max Z-score for ThCtAB.Me in femorotibial cartilage plates and subregions
Region Men Women
Mean (95% CI) SD Max
Z-score
Mean (95% CI) SD Max
Z-score
MT 1.86 (1.84e1.89) 0.21 8.8 1.62 (1.61e1.64) 0.18 9.1
cMF 2.06 (2.03e2.10) 0.29 7.2 1.70 (1.67e1.72) 0.24 6.9
MFTC 3.93 (3.88e3.98) 0.45 8.7 3.32 (3.28e3.36) 0.39 8.6
LT 2.25 (2.22e2.28) 0.26 8.7 1.95 (1.93e1.98) 0.24 8.1
cLF 1.93 (1.90e1.96) 0.25 7.7 1.65 (1.63e1.67) 0.23 7.1
LFTC 4.19 (4.14e4.24) 0.43 9.8 3.61 (3.57e3.65) 0.39 9.3
cMT 2.54 (2.49e2.58) 0.39 6.6 2.17 (2.13e2.20) 0.31 6.9
eMT 1.59 (1.57e1.62) 0.22 7.3 1.36 (1.34e1.38) 0.18 7.8
iMT 2.01 (1.98e2.04) 0.27 7.6 1.77 (1.75e1.79) 0.22 8.1
aMT 1.73 (1.70e1.75) 0.21 8.2 1.46 (1.44e1.48) 0.19 7.6
pMT 1.54 (1.52e1.57) 0.22 7.1 1.43 (1.41e1.45) 0.17 8.3
ccMF 2.54 (2.49e2.59) 0.44 5.7 2.05 (2.01e2.09) 0.37 5.6
ecMF 1.51 (1.48e1.53) 0.25 6.1 1.26 (1.24e1.28) 0.20 6.4
icMF 2.19 (2.15e2.23) 0.30 7.2 1.83 (1.80e1.85) 0.27 6.8
cLT 3.44 (3.38e3.50) 0.53 6.6 2.87 (2.82e2.93) 0.51 5.7
eLT 1.71 (1.68e1.73) 0.22 7.7 1.47 (1.45e1.49) 0.21 7.1
iLT 2.19 (2.16e2.22) 0.28 7.7 1.89 (1.86e1.91) 0.27 7.0
aLT 1.87 (1.84e1.90) 0.26 7.3 1.62 (1.60e1.64) 0.21 7.7
pLT 2.13 (2.09e2.17) 0.32 6.7 1.98 (1.95e2.01) 0.31 6.4
ccLF 2.30 (2.25e2.34) 0.36 6.4 1.97 (1.93e2.00) 0.34 5.8
ecLF 1.70 (1.68e1.73) 0.24 7.2 1.46 (1.43e1.48) 0.22 6.8
icLF 1.83 (1.80e1.86) 0.23 7.8 1.55 (1.53e1.58) 0.21 7.3
Please note that this table does not report “observed” Z-scores for patients with
knee OA, but computes theoretical maximal Z-scores based on the normal distri-
bution of cartilage thickness in various knee compartments, plates and subregions,
under the assumption that the minimal cartilage thickness in these may attain
values of “zero” in end-stage knee OA.
Fig. 2. Bar graphs showing the mean and SD of cartilage thickness of the femorotibial
cartilage plates in Framingham “normals” (no radiographic femorotibial OA), in Fra-
mingham “supernormals” (no radiographic femorotibial OA and no MRI features of
cartilage lesions), and in non-exposed OAI reference cohort (no radiographic femo-
rotibial OA, no symptoms of risk factors of knee OA) (A) Cartilage thickness in men (B)
Cartilage thickness in women.
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subregions, maximal Z-scores in men ranged from 6.0 (ccMF) to
10.0 (iMT), and in women from 6.4 (cLT) to 8.8 (eLT). The Z-scores
were very similar in non-exposed OAI participants (7.6 in men, 8.1
in women) compared with Framingham normals (7.5 and 7.3),
when averaged across compartments, plates and subregions.
Discussion
The primary objectives of this study were to establish (sex-
speciﬁc, subregional) reference values of femorotibial cartilage
thickness (ThCtAB) from a large population-based cohort. Key
ﬁndings are that medially the femur displayed thicker cartilage
than the tibia, whereas laterally, the opposite was the case. The
thickest cartilage was found in the central subregion of the LT [cLT],
and the thinnest in the external subregions of the weight-bearing
medial femur [ecMF]. Men displayed thicker cartilage than women
throughout all plates and subregions, but the maximal Z-scores
were similar between men in women. The values derived from
“supernormal” participants (with no MRI features of femorotibial
cartilage lesions in addition to normal femorotibial radiographs)
were within 0.06 mm (2.6%) of those in the “normal” subjects (KL
grade 0), and Z-scoreswere similar to those obtained form normals.
The mean values for the non-exposed OAI reference cohort were
within 0.2 mm (8.2%) of those of the Framingham normals, and
again the Z-scores were very similar for all compartments, plates
and subregions.
A potential limitation of the current study is the use of a 1.5T
protocol in the Framingham and the use of a 3T protocol in the OAI
cohort. However, a previous study that compared measurements at
1.5T and 3T face-to-face showed high agreement and no systematic
deviation of the cartilage thickness between different ﬁeld
strengths35. Also, the two studies involved somewhat different
deﬁnitions of the femoral region of interest analyzed intercondylar
bone bridge [¼short ROI] in the Framingham study; 60% criterion
[¼long ROI] in the OAI. A recent analysis36 that compared both ROIs
directly in the same subjects, however, revealed that there were no
systematic differences in cartilage thickness between the short and
long femoral ROI, respectively.
Another limitation of this study is that the subregions, as
described and deﬁned here12,15 are currently notwidely used by the
scientiﬁc community. However, the subregions are based on stan-
dard anatomical directions and thus represent aspects of the joint
surfaces that other investigators can easily refer to. Also, one must
keep in mind that three components contribute to the measured
SD: the variance between individuals, the day-to-day variation in
cartilage due, for example, to small differences in previous loading
or hydration, and the precision errors arising from segmentation
error and scanner noise. The SD reported here was 10e18% of the
mean, whereas precision errors reported in the literature ranged
from 1.5 to 3%, even when measurement were performed on
different days5,37. Therefore the reported SDs should mainly reﬂect
inter-subject variability.
Amongst different morphological parameters, the ThCtAB.Me
over the entire subchondral bone area (including denuded areas
[ThCtAB]4) determined in the current study, was previously found
to better discriminate between patients scheduled for knee
arthroplasty or tibial osteotomy and normal volunteers than
cartilage volume8. ThCtAB is conceptionally the same as normal-
ized cartilage volume (volume divided by the tAB)4,8 and can be
computed for total cartilage plates and various subregions15. Recent
cross-sectional studies found, however, surprisingly little differ-
ence in cartilage thickness between supposedly normal subjects
and participants with various grades of mild radiographic OA18,38.
The ﬁnding of greater lateral (LT) than medial tibial (MT) cartilage
Fig. 3. Representative histograms of the cartilage thickness distribution in the MT and cMF from the Framingham cohort. (A) MT cartilage thickness distribution in men (B) MT
cartilage thickness distribution in women (C) cMF cartilage thickness distribution in men (D) cMF cartilage thickness distribution in women.
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cohort of young adults aged 20e35 years8. In a smaller study of
female participants aged>40 years, the same pattern of ThCtAB.Me
values (greater in lateral than inMT, greater inmedial femur than in
MT, greater in LT than in lateral femur), and greater in medial femur
than in medial tibia). This is the ﬁrst study, however, to report
subregional reference values for cartilage thickness in both men
and women.
An interesting observation from the current study is that,
although 45% of the Framingham participants with normal PA
radiographs (KL grade 0) displayed signs of femorotibial cartilage
lesions on MRI, exclusion of these participants did not affect the
mean thickness values or maximal potential Z-scores. If anything,
the cartilage thickness in “supernormals” (normal femorotibial
radiographs and no MRI features of femorotibial cartilage lesions)
was less than in participants displaying normal X-rays but also
MRI cartilage lesions. Presence of WORMS scores >0 or denuded
areas in cases where radiographs are normal thus does not appear
to be associated with a reduction in mean cartilage thickness
throughout subregions or plates. A recent paper from the Fra-
mingham cohort showed that even participants with early
radiographic OA did not display systematically thinner cartilage
than radiographically normal participants, but signiﬁcantly higher
WORMS cartilage scores18. On the contrary, there is some recentevidence from cross-sectional38 and longitudinal39 studies that
the cartilage may undergo thickening (swelling or hypertrophy) at
the early phase of radiographic OA, and this may be a reason for
the “supernormals” to exhibit thinner cartilage than participants
with pre-radiographic cartilage lesions. For establishing reference
values of cartilage thickness in certain populations, however, it
appears to be sufﬁcient to study participants with normal
radiographs.
Similarly, the non-exposed OAI healthy reference cohort dis-
played very similar ThCtAB.Me values and Z-scores compared with
Framingham participants, despite the somewhat younger age and
smaller BMI, and the lack of risk factors for knee OA. These results
indicate that, as published previously10, knee cartilage thickness in
healthy subjects is independent of age, and that the presence/
absence of risk factors may not be associated with differences in
cartilage thickness, as long as the X-rays are normal. Also, the
results conﬁrm that the non-exposed reference cohort from the OAI
can be used as an internal control in cross-sectional studies
comparing disease-speciﬁc differences in cartilage thickness within
the OAI cohort.
T-scores (comparison with young healthy subjects) and Z-
scores (comparison with healthy subjects of similar age) are
frequently used in the diagnostics of osteoporotic bone loss,
Burgkart et al.8 and reported only moderate Z-scores (around
Table III
Framingham supernormal cohort (n¼ 376); participants without radiographic
femorotibial OA and without MRI features of femorotibial cartilage lesions (WORMS
cartilage scores 0, and no denuded areas in quantitative MRI): Mean values (mean),
95% CI of the mean SD and maximal potential Z-scores (max Z-score) for ThCtAB.Me
in femorotibial cartilage plates and subregions
Region Men Women
Mean (95% CI) SD Max
Z-score
Mean (95% CI) SD Max
Z-score
MT 1.85 (1.82e1.88) 0.21 9.0 1.62 (1.60e1.64) 0.17 9.4
cMF 2.06 (2.02e2.11) 0.29 7.1 1.68 (1.65e1.71) 0.22 7.8
MFTC 3.91 (3.84e3.99) 0.46 8.5 3.30 (3.25e3.35) 0.35 9.5
LT 2.27 (2.23e2.31) 0.24 9.3 1.96 (1.93e1.99) 0.23 8.5
cLF 1.90 (1.86e1.94) 0.25 7.6 1.62* (1.59e1.65) 0.21 7.8
LFTC 4.17 (4.10e4.24) 0.42 9.9 3.58 (3.53e3.63) 0.35 10.2
cMT 2.52 (2.46e2.58) 0.37 6.9 2.15 (2.11e2.19) 0.30 7.2
eMT 1.59 (1.56e1.63) 0.22 7.4 1.36 (1.33e1.38) 0.17 7.9
iMT 1.98 (1.94e2.02) 0.26 7.6 1.76 (1.73e1.79) 0.21 8.5
aMT 1.72 (1.68e1.75) 0.21 8.1 1.46 (1.43e1.48) 0.19 7.7
pMT 1.53 (1.50e1.56) 0.22 7.1 1.43 (1.41e1.46) 0.17 8.4
ccMF 2.54 (2.47e2.61) 0.42 6.0 2.03 (1.98e2.08) 0.33 6.2
ecMF 1.49 (1.45e1.53) 0.26 5.8 1.23 (1.21e1.26) 0.17 7.1
icMF 2.21 (2.16e2.26) 0.31 7.2 1.82 (1.78e1.85) 0.25 7.3
cLT 3.49 (3.41e3.57) 0.49 7.2 2.90 (2.83e2.96) 0.47 6.2
eLT 1.69 (1.65e1.72) 0.23 7.4 1.46 (1.44e1.49) 0.20 7.4
iLT 2.22 (2.18e2.27) 0.28 8.0 1.90 (1.87e1.93) 0.25 7.7
aLT 1.86 (1.82e1.90) 0.25 7.5 1.61 (1.58e1.63) 0.21 7.8
pLT 2.17 (2.13e2.22) 0.30 7.2 2.00 (1.96e2.04) 0.30 6.6
ccLF 2.24 (2.18e2.30) 0.35 6.4 1.92* (1.88e1.96) 0.30 6.4
ecLF 1.67 (1.64e1.71) 0.23 7.2 1.43 (1.41e1.46) 0.19 7.5
icLF 1.80 (1.77e1.84) 0.23 7.7 1.53* (1.50e1.56) 0.20 7.7
* Signiﬁcantly different compared with those of the Framingham normal
cohort that were not supernormal (n¼ 153) at P< 0.01; comparisons were
adjusted for differences in age, height, and weight. Cartilage plate and
compartment labels MT¼medial tibia, cMF¼ central (weight-bearing) medial
femur, MFTC¼medial femorotibial compartment¼MTþcMF, LT¼ lateral tibia,
cLF¼ central (weight-bearing) lateral femur, LFTC¼ lateral femorotibial com-
partment¼ LTþcLF; subregion labels: c¼ central, e¼ external, i¼ internal,
a¼ anterior, p¼ posterior.
Table IV
OAI non-exposed cohort, without femorotibial radiographic OA (KL grade 0) or
symptoms or risk factors of knee OA
Region Men Women
Mean (95% CI) SD Max
Z-score
Mean (95% CI) SD Max
Z-score
MT 1.83 (1.77e1.89) 0.20 9.1 1.62 (1.58e1.66) 0.17 9.7
cMF 2.01 (1.92e2.10) 0.28 7.1 1.71 (1.66e1.75) 0.20 8.3
MFTC 3.84 (3.71e3.98) 0.43 8.9 3.33 (3.25e3.41) 0.33 10.0
LT 2.32 (2.24e2.41) 0.27 8.6 1.95 (1.90e2.00) 0.22 8.9
cLF 1.89 (1.81e1.97) 0.25 7.4 1.64 (1.59e1.68) 0.20 8.2
LFTC 4.21 (4.08e4.35) 0.43 9.7 3.59 (3.50e3.67) 0.35 10.2
cMT 2.56 (2.44e2.67) 0.37 6.9 2.24 (2.17e2.31) 0.29 7.7
eMT 1.60 (1.54e1.67) 0.22 7.2 1.37 (1.33e1.41) 0.16 8.5
iMT 1.97 (1.91e2.03) 0.20 10.0 1.77 (1.71e1.82) 0.22 7.9
aMT 1.65 (1.59e1.71) 0.20 8.4 1.39 (1.35e1.44) 0.18 7.7
pMT 1.49 (1.42e1.56) 0.22 6.7 1.42 (1.38e1.46) 0.17 8.5
ccMF 2.49 (2.36e2.61) 0.41 6.1 2.09 (2.01e2.15) 0.29 7.3
ecMF 1.43 (1.37e1.49) 0.20 7.0 1.23 (1.19e1.27) 0.17 7.3
icMF 2.14 (2.04e2.23) 0.31 6.9 1.82 (1.76e1.87) 0.23 7.8
cLT 3.63 (3.45e3.80) 0.57 6.4 2.98 (2.87e3.09) 0.47 6.4
eLT 1.84* (1.77e1.90) 0.22 8.4 1.59* (1.55e1.64) 0.18 8.8
iLT 2.28 (2.19e2.37) 0.28 8.0 1.88 (1.81e1.94) 0.28 6.8
aLT 1.88 (1.79e1.97) 0.28 6.7 1.54* (1.49e1.59) 0.20 7.6
pLT 2.07 (1.98e2.17) 0.30 6.8 1.83* (1.77e1.90) 0.26 7.0
ccLF 2.27 (2.15e2.38) 0.38 6.0 1.99 (1.92e2.06) 0.29 6.8
ecLF 1.63 (1.55e1.70) 0.24 6.8 1.38 (1.34e1.42) 0.17 8.2
icLF 1.80 (1.73e1.87) 0.23 7.7 1.57 (1.51e1.62) 0.20 7.8
Mean values (mean), 95% CI of the mean SD and max Z-score for ThCtAB.Me in
femorotibial cartilage plates and subregions.
* Signiﬁcantly different compared with those of the Framingham normal cohort
(n¼ 309) at P< 0.01. Comparisons were adjusted for differences in age, height, and
weight. Cartilage plate and compartment labels MT¼medial tibia, cMF¼ central
(weight-bearing) medial femur, MFTC¼medial femorotibial compart-
ment¼MTþcMF, LT¼ lateral tibia, cLF¼ central (weight-bearing) lateral femur,
LFTC¼ lateral femorotibial compartment¼ LTþcLF; subregion labels: c¼ central,
e¼ external, i¼ internal, a¼ anterior, p¼ posterior.
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higher scores (around 3.8) in participants scheduled for total
knee arthroplasty. The potential maximal Z-scores (computed by
dividing the difference between the mean and zero by the inter-
subject SD of cartilage thickness in the participants) in the current
study ranged from 5.7 to 10.2 across cohorts/compartments/
plates/subregions, and were 7.4, on average, in Framingham
normals. These results indicate that a cartilage thickness loss of
around 27% is required to attain a Z-score of 2.0. Cartilage
thickness reductions of up to 20% in the medial femorotibial
cartilage plates have been observed in a cross-sectional compar-
ison of participants with medial JSN compared with a healthy
reference cohort38, suggesting that the Z-scores of cartilage
thickness loss observed in OA are only moderate.
In conclusion, this paper shows consistent mean values,
maximal Z-scores, and patterns of cartilage thickness in the fem-
orotibial joint across “normal” and “supernormal” participants of
the population-based Framingham cohort and the non-exposed
reference cohort of the OAI. Although 45% of the Framingham
participants with normal radiographs showed MRI features of
femorotibial cartilage lesions, exclusion of these participants did
not signiﬁcantly affect mean values or maximal Z-scores for carti-
lage thickness. Likewise, examination of a reference cohort without
risk factors of knee OA (the non-exposed OAI reference cohort)
produced values consistent with those from the population-based
Framingham cohort. Normal femorotibial radiographs thus appear
to be a sufﬁcient inclusion criterion for establishing reference
values for femorotibial cartilage thickness. The results indicate
that a cartilage thickness loss of around 27% is required for attaining
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The OAI participants were recruited at four clinical sites: the
University of Maryland School of Medicine (Baltimore), the Ohio
State University (Columbus), the University of Pittsburgh, and the
Memorial Hospital of Rhode Island (Pawtucket). Participants of the
non-exposed healthy reference cohort (0.B.1.) had
 No pain, aching or stiffness in either knee in the past year.
 No radiographic ﬁndings of femorotibial OA (Osteoarthritis
Research Society International (OARSI) osteophyte grade 0 and
joint space narrowing grade 0) of either knee using the clinic
reading of the baseline bilateral ﬁxed ﬂexion radiographs24.
Radiographic ﬁndings in a lateral (patello-femoral) view of the
knees were not used to determine eligibility for this group.
 No risk factors for the onset of knee OA, including
B Obesity deﬁned as a body weight of >170 lbs (77.1 kg) in
women aged 45e69, >180 lbs (81.7 kg) in women aged
70e79, >205 lbs (93 kg) in men aged 45e69, and >215 lbs
(97.5 kg) in men aged 70e79.
B History of knee injury, deﬁned as having caused difﬁculty
walking for at least a week.
B Knee surgery.
B Family history of total knee replacement in a biological parent
or sibling.
B Heberden’s nodes, deﬁned as self-reported bony enlarge-
ments of one or more distal interphalangeal joints in both
hands.
B Repetitive knee bending, deﬁned as current daily activity at
work or outside work, requiring frequent climbing, stooping,
bending, lifting, squatting or kneeling.
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